Rajesh Devraj
InvestorVenture Partner at Atlas Venture
Cambridge, Massachusetts
Writes $10M – $50M checks · typically $25M
Experience
- Rectify PharmaceuticalsPresident & CEOcurrent2022 — presentCambridge, Massachusetts, United States
- Washington University School of Medicine in St. LouisBiopharma Advisory Committeecurrent2023 — present
- Euclises Pharmaceuticals Inc.Board Director2015 — 2025Greater St. Louis
- Euclises Pharmaceuticals Inc.President and Chief Executive Officer2013 — 2014Greater St. Louis
- Sail BIOBoard Director2021 — 2024Cambridge, Massachusetts, United States
- Disarm TherapeuticsChief Scientific Officer and Co-founder2016 — 2020Cambridge, MA, USA
- Indalo TherapeuticsBoard Director2017 — 2020Cambridge, Massachusetts, United States
- Antegrin Therapeutics, LLCChairman of the Board of Managers2013 — 2016Greater St. Louis
- Padlock Therapeutics Inc.Chief Scientific Officer2014 — 2016Cambridge, Massachusetts
- Deciphera PharmaceuticalsScientific Advisory Board2012 — 2014
- Deciphera PharmaceuticalsSenior Vice-President2011 — 2012Lawrence, Kansas, United States
- Jubilant BiosysSenior Vice-President, Scientific & Portfolio Strategy2010 — 2011
- Pfizer Global Research and DevelopmentSenior Director2004 — 2010
- Pfizer Global Research and DevelopmentDirector2003 — 2004
- Pfizer Global Research and DevelopmentAssociate Director & Science Research Fellow2002 — 2003
- Pfizer Global Research and DevelopmentSenior Research Advisor and Section Head2000 — 2002
- Searle Discovery Research, Monsanto Life Sciences, Co.Project & Technology Leader1997 — 2000
- Searle Discovery Research, Monsanto Life Sciences, Co.Senior Research Investigator1996 — 1997
Skills & more
Strategic Planning4Drug Discovery96Medicinal Chemistry64Drug Design40Drug Development58Pharmaceutical Industry37Lead Change14CRO14Oncology10LC-MS13Biotechnology27Clinical Development20
+12 more
Organic ChemistryLifesciencesPharmacologyOrganic Synthesispreclinical developmentFundraisingCapital BudgetingImmunologyRInflammationAlliance-buildingClosing DealsFrom Rajesh's professional profile.
Deals · 2
Antegrin TherapeuticsBoard seat
via Atlas Venture · filed Aug 2017 · $26M raise
Euclises PharmaceuticalsBoard seat
via Atlas Venture · filed Dec 2016 · $2.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Atlas Venture
Aimee Raleigh
Principal at Atlas Venture
Bruce Booth
Partner at Atlas Venture
Chelsea Johnson
Principal at Atlas Venture
David Grayzel
Partner at Atlas Venture
Jason Rhodes
Partner at Atlas Venture
Jean-François Formela
Partner at Atlas Venture
Jernej Godec
Principal at Atlas Venture
Jodie Morrison
Venture Partner at Atlas Venture
Frequently asked questions
- Who is Rajesh Devraj?
- Venture Partner at Atlas Venture
- Where does Rajesh Devraj work?
- Rajesh Devraj is Venture Partner at Atlas Venture.
- What check size does Rajesh Devraj write?
- Rajesh Devraj typically writes checks of $10M – $50M.
- What boards does Rajesh Devraj sit on?
- Rajesh Devraj holds tracked board seats at Antegrin Therapeutics, Antegrin Therapeutics, Euclises Pharmaceuticals.
Shared employers
Also worked at Washington University School of Medicine in St. Louis18
Victoria GraceFounding Partner at Colle Capital PartnersKarlos BledsoePrincipal at Seae VenturesMukund SubramanianStrategic Advisor at Advance Venture PartnersAndrew WegrzynPrincipal at SixThirty VenturesBen ScruggsPartner at Hatteras Venture PartnersTravis ManascoPrincipal at Solas BioVentures
+ 12 more
Also worked at Padlock Therapeutics Inc.1
Also worked at Pfizer Global Research and Development152
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesBriggs MorrisonEntrepreneur Partner at MPM BioImpact
+ 146 more
Also worked at Searle Discovery Research, Monsanto Life Sciences, Co.34
Derek RappInvestor at RiverVest Venture PartnersRick RyanGeneral Partner at Cultivation CapitalMartha SchlicherGeneral Partner at Cultivation CapitalNick RosaInvestor at Sandbox IndustriesChas EggertOperating Partner at iSelect FundJohn HamerManaging Partner, DCVC Bio at DCVC (Data Collective)
+ 28 more





























